We advised the selling shareholders in a strategic M&A transaction valued at over R$60 million involving a target company specializing in laboratory testing, inspections, and certifications. The partial acquisition was carried out by a member of a multinational conglomerate operating in the same sector, aiming to strengthen its product portfolio.

Our work ensured that the sale of the stake was completed quickly and securely, in the best interests of the selling shareholders, adapting to the specific needs of the transaction in order to accommodate the commercial conditions negotiated between the parties with legal certainty and effectiveness. The Transaction was completed in July 2025. In addition to the sale of a portion of the company's capital, our firm advised the selling shareholders in negotiating a Shareholders' Agreement for the future sale of the remaining equity interests based on a buy-back arrangement. earn-out.